Triwise Capital Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
13
- Investments
-
91
- Portfolio
-
61
- Exits
-
16
Triwise Capital General Information
Company Description
Founded in 2015, Triwise Capital is a venture capital firm based in Shenzhen, China. The firm focuses on investments in the drugs, cell and gene technology, synthetic biology, bio-breeding, and high-end medical device sector startups across China.
Business Details
Website
triwise.cnYear Founded
Investor Status
Primary Investor Type
Corporate Office
- Room A1501, National Engineering Laboratory Building, Gaoxin High-Tech South Seventh Road
- Nanshan District
- Shenzhen, Guangdong
- China
Triwise Capital Investments (91)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Burgeon Therapeutics | 28-Oct-2026 | Later Stage VC | Drug Discovery | Generating Revenue | ||
| Xijia Medical | 17-Aug-2026 | Decision/Risk Analysis | Generating Revenue | |||
| NeuroXess | 03-Jul-2026 | Therapeutic Devices | Generating Revenue | |||
| Daosheng Bio | 26-Apr-2026 | Specialty Chemicals | Generating Revenue | |||
| Xijia Medical | 06-Apr-2026 | Decision/Risk Analysis | Generating Revenue | |||
| Betterway Medtech | 16-Mar-2026 | Therapeutic Devices | Generating Revenue | |||
| Gulf Biotechnology | 09-Feb-2026 | Biotechnology | Generating Revenue | |||
| Changer Medical | 05-Feb-2026 | Surgical Devices | Generating Revenue | |||
| Pet Medtech | 05-Feb-2026 | Early Stage VC | Drug Discovery | Generating Revenue | ||
| Lungshield Medical | 01-Feb-2026 | Early Stage VC | Therapeutic Devices | Generating Revenue |
Triwise Capital Exits (16)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Insight Lifetech | 05-Feb-2026 | IPO | |
| ImageneBio | 25-Jul-2025 | ||
| Qyuns | 20-Mar-2024 | ||
| Adlai Nortye | 29-Sep-2023 | ||
| Pleasure More | 17-Mar-2023 | ||
| Transwarp (Big Data) | 18-Oct-2022 | ||
| Asieris Pharmaceuticals | 07-Jan-2022 | ||
| Lansus | 24-Dec-2020 | ||
| Akesobio | 24-Apr-2020 | IPO | |
| Sinbad Tourism | 01-Jan-2020 | Out of Business |
Triwise Capital Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
Triwise Capital Co-Investors (96)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Guangdong Technology Financial Group | 3 |
|
|
||
| Co-Stone Capital |
|
|
|||
| Fuho Capital |
|
|
|||
| HSG (Hong Kong) |
|
|
|||
| Shenzhen Capital Group |
|
|
Triwise Capital FAQs
-
What is Triwise Capital?
Founded in 2015, Triwise Capital is a venture capital firm based in Shenzhen, China.
-
When was Triwise Capital founded?
Triwise Capital was founded in 2015.
-
Where is Triwise Capital headquartered?
Triwise Capital is headquartered in Shenzhen, China.
-
How many investments has Triwise Capital made?
Triwise Capital has made 91 investments.
-
What has Triwise Capital invested in?
Triwise Capital has made numerous investments in companies like Burgeon Therapeutics, Xijia Medical, and NeuroXess within the Drug Discovery, Decision/Risk Analysis, and Therapeutic Devices industries.
-
What has Triwise Capital invested in recently?
Triwise Capital's latest investment was on 28-Oct-2026 in Burgeon Therapeutics, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
